» Articles » PMID: 15361885

Hedgehog Signalling in Prostate Regeneration, Neoplasia and Metastasis

Overview
Journal Nature
Specialty Science
Date 2004 Sep 14
PMID 15361885
Citations 426
Authors
Affiliations
Soon will be listed here.
Abstract

Metastatic cancers adopt certain properties of normal cells in developing or regenerating organs, such as the ability to proliferate and alter tissue organization. We find here that activity of the Hedgehog (Hh) signalling pathway, which has essential roles in developmental patterning, is required for regeneration of prostate epithelium, and that continuous pathway activation transforms prostate progenitor cells and renders them tumorigenic. Elevated pathway activity furthermore distinguishes metastatic from localized prostate cancer, and pathway manipulation can modulate invasiveness and metastasis. Pathway activity is triggered in response to endogenous expression of Hh ligands, and is dependent upon the expression of Smoothened, an essential Hh response component that is not expressed in benign prostate epithelial cells. Monitoring and manipulating Hh pathway activity may thus offer significant improvements in diagnosis and treatment of prostate cancers with metastatic potential.

Citing Articles

Itraconazole promotes melanoma cells apoptosis via inhibiting hedgehog signaling pathway-mediated autophagy.

Jin S, Liu X, Cai L, Yan J, Li L, Dong H Front Pharmacol. 2025; 16:1545243.

PMID: 39917616 PMC: 11798931. DOI: 10.3389/fphar.2025.1545243.


Advancing ex vivo functional whole-organ prostate gland model for regeneration and drug screening.

Subbiahanadar Chelladurai K, Selvan Christyraj J, Rajagopalan K, Selvan Christyraj J Sci Rep. 2025; 15(1):3758.

PMID: 39885212 PMC: 11782681. DOI: 10.1038/s41598-025-87039-y.


Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer.

Filippi A, Deculescu-Ionita T, Hudita A, Baldasici O, Galateanu B, Mocanu M Int J Mol Sci. 2025; 26(2).

PMID: 39859345 PMC: 11766403. DOI: 10.3390/ijms26020631.


Oncogenic potential of truncated-Gli3 via the Gsk3β/Gli3/AR-V7 axis in castration-resistant prostate cancer.

Kaushal J, Raut P, Halder S, Alsafwani Z, Parte S, Sharma G Oncogene. 2025; .

PMID: 39821099 DOI: 10.1038/s41388-024-03266-z.


PlexinD1 is a driver and a therapeutic target in advanced prostate cancer.

Wei J, Wang J, Guan W, Li J, Pu T, Corey E EMBO Mol Med. 2025; 17(2):336-364.

PMID: 39748059 PMC: 11822115. DOI: 10.1038/s44321-024-00186-z.